Evidence map›Paper›PMID 42862273›Full record

ArticleEuropean radiology experimental2026

Evaluation of iodine detection and quantification limits in photon-counting CT-a phantom study.

Rebecca Titternes, Gavin Poludniowski, Torkel Bo Brismar, Patrik Nowik, Daniel Thor

Abstract readEvaluation Study
In one paragraph

Article in European radiology experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rebecca TitternesDepartment of Nuclear Medicine and Medical Radiation Physics, Karolinska University Hospital, Stockholm, Sweden. rebecca.titternes@ki.se.ORCID http://orcid.org/0000-0001-6115-3738
Gavin PoludniowskiDepartment of Nuclear Medicine and Medical Radiation Physics, Karolinska University Hospital, Stockholm, Sweden.
Torkel Bo BrismarDepartment of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Patrik NowikDepartment of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Daniel ThorDepartment of Nuclear Medicine and Medical Radiation Physics, Karolinska University Hospital, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveClinical decisions using CT iodine maps are based on evaluation of contrast enhancement, making it essential to understand how accurately CT systems detect and quantify iodine, yet quantitative evaluations remain scarce, and few studies treat iodine as an analyte for which detection threshold, quantification precision, and measurement linearity can be determined using standard laboratory-science concepts. No study has applied such concepts across photon-counting CT (PCCT) and dual-energy CT (DECT) systems. MATERIALS AND

methodsUsing head and abdominal protocols, test tubes with iodine concentrations (0.0-2.0 mg/mL) were placed in a phantom providing head- and abdomen-equivalent attenuation. Scans were performed at two dose levels per protocol, on two DECT and one PCCT system. Iodine images were reconstructed for repeated scans using varying iterative reconstruction (IR) levels. Limit-of-detection (LoD), limit-of-quantification (LoQ), and lower-limit-of-linear-interval (LLLI) were calculated for two ROI sizes (3 and 10 mm), and differences between scanners were analyzed with Welch ANOVA and Games-Howell tests (α = 0.05).

resultsPCCT demonstrated significantly lower LoD/LoQ values than the DECT systems across most protocols. For low-dose abdomen (3 mGy, medium-IR), LoD for 3 and 10 mm ROI size were 0.78 and 0.16 mg/mL (PCCT), 1.28 and 0.26 mg/mL (split-filter CT), and 1.42 and 0.57 mg/mL (dual-source CT). LoQ values were also lower for PCCT. Improvements were most pronounced in low-dose protocols, with LoD reductions up to 68% (brain) and 45% (abdomen). LLLI was similar across systems.

conclusionPCCT outperformed DECT in iodine detection and quantification, particularly in low-dose protocols. These findings highlight the potential use of reduced iodine contrast and/or radiation dose. KEY POINTS: Question Objective comparison of iodine detection and quantification performance between PCCT and DECT systems remains limited, particularly for low-iodine contrast media doses. Findings PCCT achieved significantly lower detection and quantification thresholds than conventional CT systems, particularly for small lesions and low-dose imaging protocols. Relevance statement Task-based LoD and LoQ metrics enable objective comparison of CT system performance and may provide clinically relevant thresholds for iodine detectability, quantification, and protocol optimization.

Indexed as

IodinePhantoms, ImagingTomography, X-Ray ComputedContrast MediaHumansLimit of DetectionPhotonsContrast MediaIodineContrast mediaIodineLimit of detectionPCCTQuantification

Identifiers

PMID42862273
PMCPMC13658709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.